University of California, Santa Barbara, California B.A. 06/83Biological Sciences

University of California, Los Angeles, California M.P.H. 06/85Epidemiology

University of Washington, Seattle Ph.D. 06/97Epidemiology

Personal Statement

My research interests are centered on the epidemiology of cancer and other chronic diseases, and include studies on breast cancer incidence and prevention (Premalignant Conditions), screening and diagnosis (Breast Cancer Surveillance Consortium), and survival and late effects (Breast Cancer Survival Disparities, Cancer Genetics Network)
An important focus of my work is to develop greater understanding of the 1.6-fold increased risk of breast cancer death among Hispanic vs. non-Hispanic women in New Mexico, the largest known such disparity in Hispanics. I have also assembled what may be one of the largest known cohorts of women with premalignant breast disease (n=15,000+), and am following them for breast cancer. I am also exploring the role of chronic kidney disease and other health conditions in influencing cancer survival.

Areas of Specialty

Cancer Epidemiology
Breast Cancer Survival
Benign Breast Disease
Cancer Survival Disparities
Chronic Kidney Disease




  • English

Courses Taught

Introductory Epidemiology, Clinical Translational Science Master's Degree Program

Advanced Epidemiology, Clinical Translational Science Master's Degree Program

Research and Scholarship

Hill DA, Prossnitz ER, Royce M, Nibbe A.Temporal trends in breast cancer survival by race and ethnicity: A population-based cohort study.. PLoS One. 2019 Oct 24;14(10):e0224064. doi: 10.1371/journal.pone. 0224064

Blair CK, Wiggins CL, Nibbe AM, Storlie CB, Prossnitz ER, Royce M, Lomo LC, Hill DA Obesity and survival among a cohort of breast cancer patients is partially mediated by tumor characteristics. Nature Partner Journal Breast Cancer. 2019 Oct 2;5:33. doi: 10.1038/s41523-019-0128-4.

Hill DA, Friend S, Lomo L, Wiggins C, Barry M, Prossnitz E, Royce M. Breast cancer survival, survival disparities, and guideline-based treatment. Breast Cancer Res Treat. 2018 Jul;170(2):405-414. doi: 10.1007/s10549-018-4761-7.

Hill DA, Barry M, Wiggins C, Nibbe A, Royce M, Prossnitz E, Lomo L. Estrogen receptor quantitative measures and breast cancer survival. Breast Cancer Res Treat. 2017 Dec;166(3):855-864. doi: 10.1007/s10549-017-4439-6.

Hill DA, Gilbert E, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Wiklund T, Lynch CF, Glimelius I, van’t Veer M, Storm H, Pukkala EM, Curtis R, Allan JM, Stovall M, Boice JD. Breast Cancer Risk Following Radiotherapy for Hodgkin Lymphoma: Modification by Other Risk Factors. Blood 106:411-417, 2005